Pacira Pharmaceuticals (PCRX) PT Raised to $94 at Barclays

February 26, 2021 5:35 AM EST
Get Alerts PCRX Hot Sheet
Price: $61.27 +0.33%

Rating Summary:
    14 Buy, 13 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 50
Trade Now! 
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $94.00 (from $79.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change